Skip to content
Screener

Delcath Systems DCTH Total Revenue

Total Revenue at other companies

Merit Medical Systems logo
Merit Medical SystemsMMSI
$381.88M+7.5%
Boston Scientific logo
Boston ScientificBSX
$5.44B+7.5%
Altimmune logo
AltimmuneALT
$26K+420%
TriSalus Life Sciences, Inc. logo
TriSalus Life Sciences, Inc.TLSI
$8.9M-2.9%
Wave Life Sciences logo
Wave Life SciencesWVE
$2.27M-73.9%
CTO
Citius Oncology, Inc.CTOR
$1.67M

Segments

By product

See full
HEPZATO KIT$27.16M+20.7%
CHEMOSAT$1.97M+19.1%

By geography

See full
Foreign$1.97M+19.1%

Other financials

Income statement

See full
Gross profit$26.1M+25.5%
Operating income$2.4M-7.5%
Net income$2.7M-1.1%
EPS (diluted)$0.070.0%

Balance sheet

See full
Cash & equivalents$47.5M+38.0%
Total debt$2.5M+148%
Total equity$121.1M+15.4%
Total assets$137.0M+17.2%

Cash flow

See full
Operating cash flow$5.7M-21.7%
CapEx$503.0K+26.4%
Free cash flow$5.2M-24.5%

Valuation

See full
Market cap$524.3M+57.3%
Enterprise value$479.26M+59.6%
P/E102.3×
P/S5.5×+0.7×

Profitability

See full
Gross margin87.1%+1.2pp
Operating margin-118.1%-56.8pp
Net margin1.5%+0.8pp
FCF margin18.3%+12.8pp

Returns & leverage

See full
Return on equity1.9%+1.0pp
Debt / equity0.0×
Current ratio9.8×-1.0×

Where this comes from

Reported directly by Delcath Systems in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The source filing: Delcath Systems’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 9:09 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-053956
Line itemThree months ended June 30, 2026Three months ended June 30, 2025Six months ended June 30, 2026Six months ended June 30, 2025
Product revenue$29,133$24,156$54,127$43,940
Cost of goods sold(2,985)(3,318)(6,721)(6,163)
Gross profit26,14820,83847,40637,777
Operating expenses:
Research and development expenses10,3806,88220,20411,889
Selling, general and administrative expenses13,37311,36626,44422,656
Total operating expenses23,75318,24846,64834,545
Operating income2,3952,5907583,232

Item 1. Financial Statements

FAQ

What is Delcath Systems's total revenue?
Delcath Systems (DCTH) reported total revenue of $29.13M in Q2 2026.
How has Delcath Systems's total revenue changed year-over-year?
Delcath Systems's total revenue increased by 20.6% year-over-year, from $24.16M to $29.13M.
What is the long-term trend for Delcath Systems's total revenue?
Over 4 years (2021 to 2025), Delcath Systems's total revenue has grown at a 121.3% compound annual growth rate (CAGR), from $3.56M to $85.23M.
What does total revenue mean?
The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.

Ask your AI about Delcath Systems's total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude